SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001819790-24-000056
Filing Date
2024-04-26
Accepted
2024-04-26 16:24:33
Documents
4
Period of Report
2024-06-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A tarsuspharmaceuticalsincpr.htm DEF 14A 502104
2 capture-proxycardlasttwopa.jpg GRAPHIC 188655
3 capture-proxycardpage2of2.jpg GRAPHIC 92647
4 image_0.jpg GRAPHIC 7717
  Complete submission text file 0001819790-24-000056.txt   890805
Mailing Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618
Business Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618 (949) 409-9820
Tarsus Pharmaceuticals, Inc. (Filer) CIK: 0001819790 (see all company filings)

IRS No.: 814717861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39614 | Film No.: 24884208
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)